Chemotherapy for gastric cancer

Table 2 Combination therapy for advanced gastric cancer

	Response rat (%)	Median survival (mo)
FU-based combinations
FAM	30-42	6-9
FAMTX	33-63	6
ELF	53	11
Modified-ELF	16-42	6-9.5
Cisplatin-5-FU CI synergism
PF	40	9-10
ECF	59-71	8.7
P-5-FU 48-h CI	50	9.3
P-5FU 24-h CI	58	11
Cisplatin-based combinations
EAP	33-64	9
FLEP	35	8
FLEP-type	39	11
LV5FU2-P	27	13.3
Combinations including new drugs
P-CPT11	41-58	9-12
LOHP-CPT11	50	8.5
CPT11-bolus 5-FU	22	7.6
CPT11- 5-FU CI	20	7
P-Xeloda	54.8	10.1
ECC	59	9.6
P-S-1	73-74	12
TPFU/LV	50	11-14
DP	37-56	9-11
DPF	51	9.3

CI: Continuous infusion.